Consumer involvement in the development and dissemination of chronic kidney disease guidelines : a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved..
OBJECTIVES: The involvement of consumers (people with lived experience of disease) in guidelines is widely advocated to improve their relevance and uptake. However, the approaches to consumer involvement in guidelines vary and are not well documented. We describe the consumer involvement framework of Caring for Australians and New ZealandeRs with kidney Impairment Guidelines.
STUDY DESIGN AND SETTING: We used a descriptive document analysis to collate all relevant policies, documents, e-mails, and presentations on consumer involvement in our organizations. We performed a narrative synthesis of collated data to summarize our evolving consumer involvement approach in guidelines.
RESULTS: We involve consumers at all levels of Caring for Australians and New ZealandeRs with kidney Impairment guideline development and dissemination according to their capacity, from conducting consumer workshops to inform the scope of guidelines, to including consumers as members of the guideline Working Groups and overseeing operations and governance as members of the Steering Committee and staff. Our approach has resulted in tangible outcomes including high-priority topics on patient education, psychosocial care, and clinical care pathways, and focusing the literature reviews to assess patient-important outcomes. The ongoing partnership with consumers led to the generation of consumer version guidelines to improve guideline dissemination and translation to support shared decision-making.
CONCLUSION: Meaningful consumer involvement can be achieved through a comprehensive approach across the entire lifecycle of guidelines. However, it must be individualized by ensuring that the involvement of consumers is timely and flexible. Future work is needed to assess the impact of consumer involvement in guideline development.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:170 |
|---|---|
| Enthalten in: |
Journal of clinical epidemiology - 170(2024) vom: 26. März, Seite 111330 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Scholes-Robertson, Nicole [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical practice guidelines |
|---|
| Anmerkungen: |
Date Revised 17.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.jclinepi.2024.111330 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370274539 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370274539 | ||
| 003 | DE-627 | ||
| 005 | 20240418232859.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240329s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jclinepi.2024.111330 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1379.xml |
| 035 | |a (DE-627)NLM370274539 | ||
| 035 | |a (NLM)38537911 | ||
| 035 | |a (PII)S0895-4356(24)00085-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Scholes-Robertson, Nicole |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Consumer involvement in the development and dissemination of chronic kidney disease guidelines |b a summary of a meaningful and sustainable approach developed by Caring for Australians and New ZealandeRs with kidney Impairment guidelines |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVES: The involvement of consumers (people with lived experience of disease) in guidelines is widely advocated to improve their relevance and uptake. However, the approaches to consumer involvement in guidelines vary and are not well documented. We describe the consumer involvement framework of Caring for Australians and New ZealandeRs with kidney Impairment Guidelines | ||
| 520 | |a STUDY DESIGN AND SETTING: We used a descriptive document analysis to collate all relevant policies, documents, e-mails, and presentations on consumer involvement in our organizations. We performed a narrative synthesis of collated data to summarize our evolving consumer involvement approach in guidelines | ||
| 520 | |a RESULTS: We involve consumers at all levels of Caring for Australians and New ZealandeRs with kidney Impairment guideline development and dissemination according to their capacity, from conducting consumer workshops to inform the scope of guidelines, to including consumers as members of the guideline Working Groups and overseeing operations and governance as members of the Steering Committee and staff. Our approach has resulted in tangible outcomes including high-priority topics on patient education, psychosocial care, and clinical care pathways, and focusing the literature reviews to assess patient-important outcomes. The ongoing partnership with consumers led to the generation of consumer version guidelines to improve guideline dissemination and translation to support shared decision-making | ||
| 520 | |a CONCLUSION: Meaningful consumer involvement can be achieved through a comprehensive approach across the entire lifecycle of guidelines. However, it must be individualized by ensuring that the involvement of consumers is timely and flexible. Future work is needed to assess the impact of consumer involvement in guideline development | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Clinical practice guidelines | |
| 650 | 4 | |a Consumer involvement | |
| 650 | 4 | |a Health communication | |
| 650 | 4 | |a Knowledge translation | |
| 650 | 4 | |a Patient participation | |
| 650 | 4 | |a Shared decision-making | |
| 700 | 1 | |a Guha, Chandana |e verfasserin |4 aut | |
| 700 | 1 | |a Gutman, Talia |e verfasserin |4 aut | |
| 700 | 1 | |a Howell, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Yip, Adela |e verfasserin |4 aut | |
| 700 | 1 | |a Cashmore, Brydee |e verfasserin |4 aut | |
| 700 | 1 | |a Roberts, Ieyesha |e verfasserin |4 aut | |
| 700 | 1 | |a Lopez-Vargas, Pamela |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Germaine |e verfasserin |4 aut | |
| 700 | 1 | |a MacGinley, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Synnot, Anneliese |e verfasserin |4 aut | |
| 700 | 1 | |a Craig, Jonathan C |e verfasserin |4 aut | |
| 700 | 1 | |a Jauré, Allison |e verfasserin |4 aut | |
| 700 | 1 | |a Krishnasamy, Rathika |e verfasserin |4 aut | |
| 700 | 1 | |a Tunnicliffe, David J |e verfasserin |4 aut | |
| 700 | 0 | |a Caring for Australian and New ZealandeRs with Kidney Impairment (CARI) Guidelines Steering Committee |e verfasserin |4 aut | |
| 700 | 1 | |a Krishnasamy, Rathika |e investigator |4 oth | |
| 700 | 1 | |a Lee, Vincent |e investigator |4 oth | |
| 700 | 1 | |a Boag, Jane |e investigator |4 oth | |
| 700 | 1 | |a Coolican, Helen |e investigator |4 oth | |
| 700 | 1 | |a Cullen, Vanessa |e investigator |4 oth | |
| 700 | 1 | |a Fortnum, Debbie |e investigator |4 oth | |
| 700 | 1 | |a Hassan, Hicham |e investigator |4 oth | |
| 700 | 1 | |a Jun, Min |e investigator |4 oth | |
| 700 | 1 | |a Lambert, Kelly |e investigator |4 oth | |
| 700 | 1 | |a Light, Casey |e investigator |4 oth | |
| 700 | 1 | |a Nguyen, Thu |e investigator |4 oth | |
| 700 | 1 | |a Palmer, Suetonia |e investigator |4 oth | |
| 700 | 1 | |a Scuderi, Carla |e investigator |4 oth | |
| 700 | 1 | |a See, Emily |e investigator |4 oth | |
| 700 | 1 | |a Viecelli, Andrea |e investigator |4 oth | |
| 700 | 1 | |a Walker, Rachael |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical epidemiology |d 1991 |g 170(2024) vom: 26. März, Seite 111330 |w (DE-627)NLM012614815 |x 1878-5921 |7 nnns |
| 773 | 1 | 8 | |g volume:170 |g year:2024 |g day:26 |g month:03 |g pages:111330 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jclinepi.2024.111330 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 170 |j 2024 |b 26 |c 03 |h 111330 | ||